Darb-ESA 40 Injection
Marketer
Septalyst Lifesciences Pvt.Ltd.
Salt Composition
Darbepoetin alfa (40mcg)
Overview Darb-ESA 40 Injection
Erythropoietin alfa (Darb-ESA 40 Injection) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. Administered under medical supervision, Darb-ESA 40 Injection necessitates careful use due to potential serious adverse reactions. Expert medical guidance is crucial; patients must adhere strictly to their physician's instructions. Common side effects may include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms suggestive of dangerously elevated blood pressure—severe headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests, monitoring electrolytes (like potassium), hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, intending to conceive, or nursing individuals must consult their doctor regarding its safety.
Primary Ingredients of Darb-ESA 40 Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Darb-ESA 40 Injection
Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia
Major Benefits of Darb-ESA 40 Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Darb-ESA 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darb-ESA 40 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Darb-ESA 40 Injection works:
Darb-ESA 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell generation within the bone marrow, the blood cell-producing tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darb-ESA 40 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darb-ESA 40 Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Limited evidence suggests that Darb-ESA 40 Injection may transfer into breast milk, posing a potential risk to nursing infants. Therefore, its use while breastfeeding is likely inadvisable.
DrivingSAFE
Driving ability is typically unaffected by Darb-ESA 40 Injection.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Darb-ESA 40 Injection presents a safe treatment option. No alteration of the Darb-ESA 40 Injection dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Darb-ESA 40 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Darb-ESA 40 Injection :
Should you forget a Darb-ESA 40 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darb-ESA 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Erythropoietin-stimulating drug |
3,018 People bought this recently